On the other hand, in a randomized, double-blind study of Bo et al. [71] conducted on a group of 192 people suffering from DM2, the use of resveratrol did not bring any statistically significant changes in biochemical markers such as: CRP (C-reactive-protein), BMI (Body Mass Index), blood pressure, HbA1c and others. This evidence concerns the gene CRP and myotonic dystrophy type 2.